Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03922802 · ClinicalTrials.gov registry record · NA
SCI Acute Intermittent Hypoxia and Non-Invasive Spinal Stimulation Combined With Gait Training
A NA study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03922802 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 14 participants.
The verdict
NCT03922802, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This is a single blind, sham controlled crossover trial that will evaluate the effectiveness of acute intermittent hypoxia therapy (AIH) combined with transcutaneous (non-invasive) spinal cord stimulation on gait and balance function for individuals after spinal cord injury.
Interventions
- DEVICE Acute Intermittent Hypoxia + Non Invasive Spinal Cord Stimulation + Gait Training
- OTHER Sham Acute Intermittent Hypoxia + Non Invasive Spinal Cord Stimulation + Gait Training
- OTHER Sham Acute Intermittent Hypoxia + Sham Non Invasive Spinal Cord Stimulation + Gait Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2023-01-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03922802
The ClinicalTrials.gov registry entry for NCT03922802 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Acute Intermittent Hypoxia + Non Invasive Spinal Cord Stimulation + Gait Training is the first listed.
NCT03922802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03922802 about?
NCT03922802 is a clinical study titled "SCI Acute Intermittent Hypoxia and Non-Invasive Spinal Stimulation Combined With Gait Training". This is a single blind, sham controlled crossover trial that will evaluate the effectiveness of acute intermittent hypoxia therapy (AIH) combined with transcutaneous (non-invasive) spinal cord stimulation on gait and balance function for individuals after spinal cord injury.
What is the current status of trial NCT03922802?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-12-01. Estimated completion is 2023-01-03.
What interventions are being tested in trial NCT03922802?
The interventions under investigation include: Acute Intermittent Hypoxia + Non Invasive Spinal Cord Stimulation + Gait Training (DEVICE), Sham Acute Intermittent Hypoxia + Non Invasive Spinal Cord Stimulation + Gait Training (OTHER), Sham Acute Intermittent Hypoxia + Sham Non Invasive Spinal Cord Stimulation + Gait Training (OTHER).
Who is sponsoring clinical trial NCT03922802?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.